Search

everythinglearnresearchcommunity

for

Search:↓

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

COVID-19 can cause various skin issues, helping doctors diagnose it early.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Thallium poisoning can cause serious eye problems and other severe health issues.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Hair mineral content can help diagnose certain common illnesses.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Hansraj is effective for various health issues but should not be used during pregnancy.

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

A young Russian girl with Meier-Gorlin syndrome has two new mutations in the CDC6 gene.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Cryptococcoid Sweet syndrome can be linked to hydralazine use and multiple autoantibodies, requiring high clinical suspicion and more research.

The Pomeranian recovered well after treatment for pneumonia and demodecosis.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.